MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF USDMIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF USDMIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF USD

MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF USD

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪59.14 M‬USD
Fund flows (1Y)
‪−4.93 M‬USD
Dividend yield (indicated)
Discount/Premium to NAV
−0.06%
Shares outstanding
‪897.82 K‬
Expense ratio
0.68%

About MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF USD


Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Global X
Inception date
Jul 25, 2019
Index tracked
Solactive China Biotech Index
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Income tax type
Capital Gains
Primary advisor
Mirae Asset Global Investments (Hong Kong) Ltd.
ISIN
HK0000516697
The Global X China Biotech ETF seeks to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Underlying Index.

Broaden your horizons with more funds linked to 9820 via country, focus, and more.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Cash
Stock breakdown by region
12%87%
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
9820 trades at 8.930 USD today, its price has risen 0.76% in the past 24 hours. Track more dynamics on 9820 price chart.
9820 net asset value is 8.59 today — it's risen 10.84% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
9820 assets under management is ‪59.14 M‬ USD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
9820 price has risen by 7.97% over the last month, and its yearly performance shows a 62.51% increase. See more dynamics on 9820 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 10.84% over the last month, showed a 33.87% increase in three-month performance and has increased by 58.90% in a year.
9820 fund flows account for ‪−38.68 M‬ USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
9820 invests in stocks. See more details in our Analysis section.
9820 expense ratio is 0.68%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, 9820 isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, 9820 technical analysis shows the strong buy rating and its 1-week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 9820 shows the buy signal. See more of 9820 technicals for a more comprehensive analysis.
No, 9820 doesn't pay dividends to its holders.
9820 trades at a premium (0.14%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
9820 shares are issued by Mirae Asset Global Investments Co., Ltd.
9820 follows the Solactive China Biotech Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Jul 25, 2019.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.